The Basque Country strengthens its cooperation with Nouvelle-Aquitaine in innovation, biosciences and artificial intelligence

1–2 December 2025
The Euskadi–Nouvelle-Aquitaine institutional and business mission brought together organisations, technology centres, companies and health and biosciences stakeholders from both regions. Across two days, the mission focused on strengthening strategic alliances, driving innovation and identifying new collaboration opportunities in health, biosciences and applied AI.

The mission began with a visit to SOPHiA GENETICS, where the Basque delegation learned how the company’s AI-based platform accelerates the diagnosis of cancer and rare diseases through advanced genomic analysis.

In the afternoon, the delegation visited IHU LIRYC – Heart Rhythm Disease Institute and FineHeart, European leaders in arrhythmia research, advanced cardiac therapies and implantable medical devices such as FLOWMAKER®.

The day concluded with an institutional reception at La Cité du Vin, where organisations and companies from both territories explored new opportunities for cross-border collaboration.

The second day opened at the Hôtel de Région, highlighting the strategic value of collaboration between the two regions to drive innovation in health, AI and advanced technologies.

During the B2B sessions, participating organisations identified synergies in medical devices, AI for health, biotechnology and knowledge transfer, paving the way for future joint initiatives.

The Basque delegation also took part in the AI Conference in Biosciences, with contributions from Roberto Bilbao (BIOEF) and Sergio Muñoz Lezcano, PhD (TECNALIA), sharing insights on the role of AI in biomedical research and diagnostics.

The mission concluded with a visit to CEVA Santé Animale, an international reference in the One Health approach.

Across two intense and productive days, the Basque Country strengthened its ties with Nouvelle-Aquitaine, generated new collaboration pathways and reinforced its position as a leading European hub for health and biosciences innovation.